Given its impact on cancer stemness and EMT, we postulate that suppressing RAB4A expression or inhibiting its function would likely halt tumor growth and metastasis, and hence is worthy of future evaluation as a therapeutic target. This evidence concerns the gene RAB4A and neoplasm.